400
Participants
Start Date
February 1, 2025
Primary Completion Date
October 31, 2025
Study Completion Date
December 31, 2025
Control group: silicone adhesive sutureless fixation device
"The standard care consists of:~* Application of hemostasis at the point of insertion for 2 minutes post puncture or until bleeding stops.~* Fix with clear polyurethane dressing (3M®-1655 Tegaderm™ IV), cyanoacrylate glue (SecurePortIV®) and silicone adhesive sutureless fixation device (3300MWA Grip-Lok®)."
Intervention Group: zinc oxide sutureless fixation device
"Alternative care consisted of:~* Application of haemostasis at the insertion site for 2 minutes post-puncture or until cessation of bleeding.~* Fixation with clear polyurethane dressing (3M®-1655 Tegaderm™ IV), cyanoacrylate glue (SecurePortIV®) and zinc oxide sutureless fixation device (2200NUZA Grip-Lok®)."
PICC
"The PICC lines used in the study will all be third-generation polyurethane and of the commercial brands:~* PowerPICC™ 4, 5 and 6 Fr from BD~* Maxflo expert™ 5 and 6 Fr from Vygon"
Midline
"The midline lines used in the study will be second or third generation polyurethane and of the commercial brands:~* PowerMidline™ 4 Fr from BD~* Arrow® Midline 4Fr from Arrow"
Ultrasound scanner
All punctures will be performed under ultrasound guidance.
RECRUITING
Arnau de Vilanova Hospital, Lleida
COMPLETED
Hospital Universitari Arnau de Vilanova, Lleida
Official College of Nurses of Lleida
UNKNOWN
Institut Catala de Salut
OTHER_GOV
Hospital Arnau de Vilanova
OTHER